# ObsEva

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obseva

- Industry: Pharmaceuticals
- Headquarters: Geneva, Switzerland
- Website: www.obseva.com
- Total disclosed funding: $93M
- Latest round: Series B (Nov 23, 2015)
- Investors on record: 8

## About

Established in 2012 and based in Geneva, Switzerland, ObsEva SA operates as a biopharmaceutical company that develops drugs for women’s reproductive health and pregnancy conditions.

## Funding rounds

- Series B, Nov 23, 2015, $59M — New Enterprise Associates, OrbiMed Advisors, Sofinnova Partners, Sofinnova Investments, HBM Partners, Novo Holdings, M Ventures, Rock Springs Capital
- Series A, Aug 29, 2013, $34M — Sofinnova Partners, Sofinnova Investments, Novo Holdings, M Ventures

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B
- Novo Holdings — Series A, Series B
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- Rock Springs Capital — Series B